Jonathan Kabakoff is a Senior Principal – Science and Technology at Alexandria Real Estate Equities, Inc. and its strategic venture capital arm, Alexandria Venture Investments. The firm targets companies operating in the fields of biopharma, diagnostics, agtech, research tools, life science and technology sectors. Alexandria Venture Investments provides financing for seed, early and growth stage capital requirements.Senior Vice President of Science & TechnologyCo-Chief Executive Officer & Co-Chief Financial Officer While at Alexandria, he has led venture capital investments in more than 40 life science companies primarily in the areas of therapeutics, diagnostics, and life science research tools.
Prior to joining Alexandria, he held research positions at Gen-Probe, Genoptix, and the Burnham Institute for Medical Research. Mr. Kabakoff received an honorable mention in the first annual Biocom Life Science Catalyst Awards in 2016. In his role, Mr. Kabakoff is responsible for strategic venture capital investments, business development, and tenant underwriting in Alexandria’s San Diego and Seattle cluster locations. He is on the board of SparkBio, an invitation-only networking group that brings together up-and-coming life science professionals in San Diego, and is a member of the Biocom Capital Development Committee. Joseph Hakman is Co-COO/Chief Strategic Transactions Ofcr at Alexandria Venture Investments. Company profile page for Alexandria Venture Investments LLC including stock price, company news, press releases, executives, board members, and contact information Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories leased to tenants in the life science and technology industries. Find RelSci relationships, employment history, board memberships, donations, awards, and more.Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.Senior Vice President, Science & TechnologyStay informed and up-to-date on your network with RelSci news and business alerting service. Mr. Kabakoff holds a BS in Chemistry from Stanford University.
The company is named after Alexandria, Egypt because of that city's connection to science. The company was founded by Misti Ushio, Milica Radisic, Yimu Zhao, Gordana Vunjak-Novakovic, Kacey Ronaldson, Boyang Zhang and Blake Stevens on October 22, 2014 and is headquartered in New York, NY.Browse in-depth profiles on 11 million influential people and organizations. alexandria capital is an investment & wealth advisory firm serving clients with a strong conviction that our clients come first in everything we do Since 1987, Alexandria Capital has steadily grown in size and scope, providing our clients with an array of custom investment solutions and personalized “high touch” planning guidance that extends beyond traditional financial advice. Their team is focused on providing investment capital to innovative life science and technology entities through Alexandria Venture Investments, our strategic venture capital arm. Senior Principal Alexandria Venture Investments Jonathan Kabakoff is a Senior Principal – Science and Technology at Alexandria Real Estate Equities, Inc. and its strategic venture capital arm, Alexandria Venture Investments.
Locus Biosciences, Inc. purchases EpiBiome, Inc. from ChinaRock Capital Management Ltd. (Venture Capital), Alexandria Venture Investments LLC, SV Tech Ventures, Inc.CSL Limited, CSL Behring LLC purchase Calimmune, Inc. from TVP Management Co. LLC, Alexandria Venture Investments LLC, AbbVie Biotech Ventures, Inc.Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.TARA Biosystems, Inc. develops organ-on-a-chip platform. Mr. Kabakoff currently serves as an Observer on the Boards of Metacrine, Forge Therapeutics, and Singular Genomics Systems.
Alexandria Venture Investments Suggest edits ... Venture capital (Series B) ($143M) Affinia Therapeutics: Venture capital (Series A) ($60M) Redpin Therapeutics: Venture capital (Series A) ($15.5M) Main Co-investors. The company also has a venture capital arm, Alexandria Venture Investments, which invests in life sciences firms.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. Alexandria Venture Investments was ranked the #1 venture capital investor in the healthcare sector by Forbes in 2018.
Matt Macey Contract, Martin Garrix Tv Show, Pune Weather Today, Sunny's Restaurant, Huntington Beach, Wait A Minute Willow Smith Lyrics, Beverly Johnson Elle,